53 related articles for article (PubMed ID: 8520037)
1. Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry.
Hofmann AF
Gut; 2003 Sep; 52(9):1239-41. PubMed ID: 12912852
[No Abstract] [Full Text] [Related]
2. Shotgun cholanomics of ileal fluid.
Chen Y; Ogundare M; Williams CM; Wang Y; Wang Y; Sewell GW; Smith PJ; Rahman FZ; O'Shea N; Segal AW; Griffiths WJ
Biochimie; 2013 Mar; 95(3):461-3. PubMed ID: 22986022
[TBL] [Abstract][Full Text] [Related]
3. The Role of Bile Acids in Pancreatic Cancer.
Wang Y; Xu H; Zhang X; Ma J; Xue S; Shentu D; Mao T; Li S; Yue M; Cui J; Wang L
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38284711
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Dissolution and Oral Bioavailability of Ursodeoxycholic Acid with a Spray-Dried pH-Modified Extended Release Formulation.
Lee J; Lee CH; Lee JG; Jeon SY; Choi MK; Song IS
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631622
[TBL] [Abstract][Full Text] [Related]
5. Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.
Lanzini A; De Tavonatti MG; Panarotto B; Scalia S; Mora A; Benini F; Baisini O; Lanzarotto F
Gut; 2003 Sep; 52(9):1371-5. PubMed ID: 12912872
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of ursodeoxycholic acid, an enterohepatic drug.
Hofmann AF
Scand J Gastroenterol Suppl; 1994; 204():1-15. PubMed ID: 7824870
[TBL] [Abstract][Full Text] [Related]
7. Influence of cholestasis on absorption of ursodeoxycholic acid.
Sauer P; Benz C; Rudolph G; Klöters-Plachky P; Stremmel W; Stiehl A
Dig Dis Sci; 1999 Apr; 44(4):817-22. PubMed ID: 10219843
[TBL] [Abstract][Full Text] [Related]
8. [Retrograde ileal bile acid tolerance test--experimental and clinical study].
Taruishi M; Ashida T; Shibata Y
Hokkaido Igaku Zasshi; 1994 May; 69(3):574-83, 585. PubMed ID: 7927182
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of total serum bile acids concentration and bile acid profiles in healthy cats after oral administration of ursodeoxycholic acid.
Day DG; Meyer DJ; Johnson SE; Weisbrode SE; Thudium DT; Rhodes DC
Am J Vet Res; 1994 Oct; 55(10):1474-8. PubMed ID: 7998707
[TBL] [Abstract][Full Text] [Related]
10. Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
Chazouillères O; Marteau P; Haniche M; Jian R; Poupon R
Dig Dis Sci; 1996 Dec; 41(12):2417-22. PubMed ID: 9011452
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
12. Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment.
Stiehl A
Ital J Gastroenterol; 1995 May; 27(4):193-5. PubMed ID: 8520037
[TBL] [Abstract][Full Text] [Related]
13. Bile acids as drugs: principles, mechanisms of action and formulations.
Hofmann AF
Ital J Gastroenterol; 1995 Mar; 27(2):106-13. PubMed ID: 7579591
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
